NETest Validated as Reliable Biomarker for PRRT
Recent research spearheaded by Lisa Bodei, MD and published in the Journal of Nuclear Medicine (April '23) has validated the role of the NETest as a predictor of the effectiveness of PRRT in treating NETs.